Abstract:We herein report the synthesis, characterization, and anticancer activity of a series of iridium(III) and ruthenium(II) half-sandwich complexes of the type 6 [(Cp-x/arene)M((PO)-O-boolean AND)Cl]PF6 (M = Ir, Cp-x = pentamethylcyclopentadienyl (Cp*) or its phenyl (Cp-xPh = C5Me4C6H5) or biphenyl (Cp-xbiPh = C5Me4C6H4C6H5) derivatives; M = Ru, arene = p-cymene (p-cym); (PO)-O-boolean AND = phosphine phosphonic amide ligand (PPOA)). The X-ray crystal structures of all complexes, in which the ligand can form six-membered rings with the metal center, have been determined. All of the complexes show remarkable anticancer activities toward HeLa and A549 cancer cells, activities which are higher than that of the clinical anticancer drug cisplatin. The incorporation of phenyl substituents on the Cp* ring for iridium(III) complexes results in little variation in their anticancer activities. These results can be attributed to the combinatorial action of the metal and PPOA ligand. Hydrolysis and DNA cleavage are not the major mechanisms of action. These complexes show potent catalytic activity in the transfer hydrogenation of NADH to NAD(+). Additionally, complexes [(eta(5)-C5Me5)Ir((PO)-O-boolean AND)Cl]PF6 (1) and [(eta(6)-p-cym)Ru((PO)-O-boolean AND)Cl]PF6 (4) arrest cell cycles at S and G(2)/M phase and S phase, respectively. Complexes 1 and 4 both can induce apoptosis of HeLa cancer cells. Reactive oxygen species (ROS) and mitochondrial membrane potential tests were also performed to explore the mechanism of action. When the concentration of the complexes is increased, the amount of reactive oxygen species (ROS) increases dramatically and the mitochondrial membrane potential decreases significantly in HeLa cancer cells. Overall, cell stress including cell cycle perturbation, apoptosis induction, increase in ROS level, and loss of mitochondrial membrane potential contributes to the anticancer potency of these complexes. Interestingly, the use of confocal microscopy provides insights into the microscopic mechanism in which the typical and most active complex 1 can damage lysosomes. This type of complex represents a potent platform for development of metal anticancer drugs.

Triphenylamine-Appended Half-Sandwich Iridium(III) Complexes and Their Biological Applications.

Half-sandwich Iridium(III) Complexes with Triphenylamine-Substituted Dipyridine Frameworks and Bioactivity Applications

Triphenylamine and carbazole‐modified iridiumIII 2‐phenylpyridine complexes: Synthesis, anticaner application and targeted research

Half-sandwich Iridium(iii) Complexes with Α-Picolinic Acid Frameworks and Antitumor Applications.

In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes

Half-sandwich Iridium III N-heterocyclic carbene antitumor complexes and biological applications.

Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging.

Synthesis and Antineoplastic Applications of TPE Appended Organometallic Iridium(III) Complexes.

Lysosome-Targeted Potent Half-Sandwich Iridium(Iii) Alpha-Diimine Antitumor Complexes

Half-sandwich Iridium N-heterocyclic Carbene Anticancer Complexes

Half-sandwich Iridium(III) Benzimidazole-Appended Imidazolium-Based N-heterocyclic Carbene Complexes and Antitumor Application.

Lysosome-Targeted Phosphine-Imine Half-Sandwich Iridium(III) Anticancer Complexes: Synthesis, Characterization, and Biological Activity

Design and Anticancer Behaviour of Cationic/neutral Half-Sandwich Iridium (III) Imidazole-Phenanthroline/phenanthrene Complexes

Effects of structurally varied fluorescent half-sandwich iridium(III) Schiff base complexes on A549 cell line

Design and anticancer behaviour of cationic/neutral half-sandwich iridium(III) imidazole-phenanthroline/phenanthrene complexes

Potent Half-Sandwich Iridium(III) and Ruthenium(II) Anticancer Complexes Containing a P^O-Chelated Ligand

Organometallic ruthenium and iridium phosphorus complexes: Synthesis, cellular imaging, organelle targeting and anticancer applications: Organometallic Complexes Synthesis and Applications

Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups

Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.

Organometallic Half-Sandwich Iridium Anticancer Complexes

Highly Potent Half- Sandwich Iridium and Ruthenium Complexes As Lysosome- Targeted Imaging and Anticancer Agents